| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/14/2023 | 19.81% | Keybanc | $180 → $205 | Maintains | Overweight |
| 07/13/2023 | 8.12% | Morgan Stanley | $170 → $185 | Maintains | Overweight |
| 07/12/2023 | -0.64% | Raymond James | $155 → $170 | Maintains | Outperform |
| 06/29/2023 | 8.12% | B of A Securities | $165 → $185 | Maintains | Buy |
| 06/28/2023 | -8.83% | Goldman Sachs | $140 → $156 | Maintains | Neutral |
| 06/27/2023 | -0.64% | Truist Securities | $154 → $170 | Maintains | Buy |
| 06/26/2023 | -0.64% | Morgan Stanley | $170 → $170 | Reiterates | Overweight → Overweight |
| 06/21/2023 | 11.05% | Wolfe Research | → $190 | Upgrades | Peer Perform → Outperform |
| 06/20/2023 | -0.64% | Morgan Stanley | → $170 | Reiterates | → Overweight |
| 06/12/2023 | -0.64% | Morgan Stanley | → $170 | Reiterates | → Overweight |
| 06/05/2023 | 2.28% | Baird | $160 → $175 | Maintains | Outperform |
| 05/23/2023 | 5.2% | Guggenheim | $165 → $180 | Maintains | Buy |
| 05/02/2023 | -17.59% | Rosenblatt | $110 → $141 | Maintains | Neutral |
| 04/26/2023 | -3.57% | Guggenheim | $155 → $165 | Maintains | Buy |
| 04/26/2023 | -0.64% | Canaccord Genuity | $150 → $170 | Maintains | Buy |
| 04/26/2023 | -24.02% | Loop Capital | $110 → $130 | Maintains | Hold |
| 04/26/2023 | -21.1% | Deutsche Bank | $130 → $135 | Maintains | Hold |
| 04/26/2023 | -3.57% | B of A Securities | $143 → $165 | Maintains | Buy |
| 04/26/2023 | -29.87% | Credit Suisse | → $120 | Reiterates | → Neutral |
| 04/26/2023 | -6.49% | Benchmark | $150 → $160 | Maintains | Buy |
| 04/26/2023 | -0.64% | Morgan Stanley | $160 → $170 | Maintains | Overweight |
| 04/26/2023 | -9.41% | Raymond James | $130 → $155 | Maintains | Outperform |
| 04/26/2023 | 5.2% | Keybanc | $160 → $180 | Maintains | Overweight |
| 04/24/2023 | -24.02% | Deutsche Bank | $115 → $130 | Maintains | Hold |
| 04/21/2023 | -12.33% | Benchmark | $140 → $150 | Maintains | Buy |
| 04/21/2023 | -21.1% | Goldman Sachs | $111 → $135 | Maintains | Neutral |
| 04/21/2023 | -6.49% | Morgan Stanley | $130 → $160 | Maintains | Overweight |
| 04/19/2023 | -9.99% | Truist Securities | $132 → $154 | Maintains | Buy |
| 04/18/2023 | -6.49% | Keybanc | $140 → $160 | Maintains | Overweight |
| 03/22/2023 | -9.41% | Guggenheim | $120 → $155 | Upgrades | Neutral → Buy |
| 02/06/2023 | 5.2% | Wells Fargo | $121 → $180 | Upgrades | Equal-Weight → Overweight |
| 02/06/2023 | -6.49% | Atlantic Equities | → $160 | Upgrades | Neutral → Overweight |
| 02/02/2023 | -22.85% | Truist Securities | $115 → $132 | Maintains | Buy |
| 02/01/2023 | -21.1% | JP Morgan | $120 → $135 | Maintains | Overweight |
| 02/01/2023 | -24.02% | Morgan Stanley | $105 → $130 | Maintains | Overweight |
| 02/01/2023 | -15.25% | Barclays | $131 → $145 | Maintains | Overweight |
| 02/01/2023 | -35.71% | Rosenblatt | $87 → $110 | Maintains | Neutral |
| 02/01/2023 | -24.02% | Pivotal Research | $100 → $130 | Maintains | Hold |
| 02/01/2023 | -24.02% | Raymond James | $110 → $130 | Maintains | Outperform |
| 02/01/2023 | -18.18% | Keybanc | $125 → $140 | Maintains | Overweight |
| 01/30/2023 | -24.02% | Benchmark | $125 → $130 | Maintains | Buy |
| 01/25/2023 | -29.87% | JP Morgan | $115 → $120 | Maintains | Overweight |
| 01/25/2023 | -23.44% | Barclays | $135 → $131 | Maintains | Overweight |
| 01/12/2023 | -44.48% | Jefferies | $115 → $95 | Downgrades | Buy → Hold |
| 12/19/2022 | -38.63% | Morgan Stanley | $115 → $105 | Maintains | Overweight |
| 11/01/2022 | -49.15% | Rosenblatt | $112 → $87 | Maintains | Neutral |
| 10/28/2022 | -32.79% | Truist Securities | $125 → $115 | Maintains | Buy |
| 10/27/2022 | -18.18% | Citigroup | $145 → $140 | Maintains | Buy |
| 10/26/2022 | -32.79% | Morgan Stanley | $120 → $115 | Maintains | Overweight |
| 10/26/2022 | -21.1% | Barclays | $164 → $135 | Maintains | Overweight |
| 10/26/2022 | -33.37% | Goldman Sachs | $133 → $114 | Maintains | Neutral |
| 10/26/2022 | -29.28% | Wells Fargo | $132 → $121 | Maintains | Equal-Weight |
| 10/26/2022 | -35.71% | Raymond James | $150 → $110 | Maintains | Outperform |
| 10/26/2022 | -26.94% | Keybanc | $135 → $125 | Maintains | Overweight |
| 10/24/2022 | -38.63% | Deutsche Bank | $115 → $105 | Maintains | Hold |
| 10/21/2022 | -24.02% | JP Morgan | $155 → $130 | Maintains | Overweight |
| 10/21/2022 | -21.1% | Keybanc | $148 → $135 | Maintains | Overweight |
| 10/20/2022 | -49.15% | Piper Sandler | → $87 | Initiates Coverage On | → Neutral |
| 10/12/2022 | -29.87% | Morgan Stanley | $140 → $120 | Maintains | Overweight |
| 10/07/2022 | -26.94% | Truist Securities | $150 → $125 | Maintains | Buy |
| 09/07/2022 | -34.54% | Rosenblatt | $118 → $112 | Maintains | Neutral |
| 07/28/2022 | -17.01% | UBS | $185 → $142 | Maintains | Neutral |
| 07/28/2022 | -15.25% | Citigroup | $150 → $145 | Maintains | Buy |
| 07/28/2022 | -31.03% | Rosenblatt | $101 → $118 | Maintains | Neutral |
| 07/28/2022 | -13.5% | Keybanc | $146 → $148 | Maintains | Overweight |
| 07/26/2022 | -14.67% | Keybanc | $210 → $146 | Maintains | Overweight |
| 07/25/2022 | -18.18% | Morgan Stanley | $170 → $140 | Maintains | Overweight |
| 07/07/2022 | 34.42% | Evercore ISI Group | $235 → $230 | Maintains | Outperform |
| 07/07/2022 | -12.33% | Citigroup | $165 → $150 | Maintains | Buy |
| 06/29/2022 | -15.25% | JP Morgan | $150 → $145 | Maintains | Overweight |
| 06/15/2022 | -27.53% | Wells Fargo | → $124 | Upgrades | Underweight → Equal-Weight |
| 06/10/2022 | -22.27% | Goldman Sachs | $150 → $133 | Maintains | Neutral |
| 06/09/2022 | -4.15% | B of A Securities | $137 → $164 | Maintains | Buy |
| 06/06/2022 | -12.33% | Raymond James | → $150 | Upgrades | Market Perform → Outperform |
| 04/29/2022 | -0.64% | Morgan Stanley | $225 → $170 | Maintains | Overweight |
| 04/29/2022 | -3.57% | Citigroup | $240 → $165 | Maintains | Buy |
| 04/28/2022 | -0.64% | Barclays | $280 → $170 | Maintains | Overweight |
| 04/28/2022 | -40.97% | Wells Fargo | $153 → $101 | Maintains | Underweight |
| 04/28/2022 | -40.97% | Rosenblatt | $150 → $101 | Maintains | Neutral |
| 04/28/2022 | -35.71% | Pivotal Research | → $110 | Downgrades | Buy → Hold |
| 04/28/2022 | 22.74% | Keybanc | $235 → $210 | Maintains | Overweight |
| 04/27/2022 | -44.48% | Guggenheim | $200 → $95 | Downgrades | Buy → Neutral |
| 04/19/2022 | -12.33% | Rosenblatt | → $150 | Initiates Coverage On | → Neutral |
| 04/14/2022 | 37.35% | Keybanc | $260 → $235 | Maintains | Overweight |
| 04/08/2022 | 31.5% | Morgan Stanley | $300 → $225 | Maintains | Overweight |
| 04/04/2022 | 8.12% | UBS | $275 → $185 | Maintains | Neutral |
| 03/11/2022 | -18.18% | Deutsche Bank | → $140 | Initiates Coverage On | → Hold |
| 02/08/2022 | 53.13% | B of A Securities | $352 → $262 | Maintains | Buy |
| 02/03/2022 | -10.58% | Wells Fargo | $200 → $153 | Maintains | Underweight |
| 02/03/2022 | 39.1% | Credit Suisse | $270 → $238 | Maintains | Neutral |
| 02/03/2022 | 28.58% | Rosenblatt | $350 → $220 | Maintains | Buy |
| 02/03/2022 | 63.65% | Barclays | $310 → $280 | Maintains | Overweight |
| 02/01/2022 | 75.34% | Morgan Stanley | $350 → $300 | Maintains | Overweight |
| 01/31/2022 | 40.27% | Citigroup | → $240 | Upgrades | Neutral → Buy |
| 01/26/2022 | 40.27% | Monness, Crespi, Hardt | $380 → $240 | Maintains | Buy |
| 11/24/2021 | 75.34% | Benchmark | → $300 | Initiates Coverage On | → Buy |
| 11/01/2021 | — | Bernstein | Upgrades | Underperform → Market Perform | |
| 10/28/2021 | 104.56% | Morgan Stanley | $325 → $350 | Maintains | Overweight |
| 10/28/2021 | 81.18% | Barclays | $300 → $310 | Maintains | Overweight |
| 10/28/2021 | 113.33% | Keybanc | $340 → $365 | Maintains | Overweight |
| 09/24/2021 | 16.89% | DZ Bank | → $200 | Initiates Coverage On | → Sell |
| 09/13/2021 | 51.96% | Goldman Sachs | → $260 | Initiates Coverage On | → Neutral |
| 09/07/2021 | 98.71% | Keybanc | → $340 | Upgrades | Sector Weight → Overweight |
| 07/30/2021 | 57.8% | Truist Securities | $290 → $270 | Maintains | Buy |
| 07/29/2021 | 89.95% | Morgan Stanley | $350 → $325 | Maintains | Overweight |
| 07/29/2021 | 40.27% | UBS | $235 → $240 | Upgrades | Sell → Neutral |
| 07/29/2021 | 54.88% | Guggenheim | $245 → $265 | Upgrades | Neutral → Buy |
| 07/29/2021 | 57.8% | Credit Suisse | $315 → $270 | Maintains | Neutral |
| 07/26/2021 | -0.64% | Redburn Partners | → $170 | Downgrades | Neutral → Sell |
| 06/08/2021 | 60.72% | Citigroup | $310 → $275 | Maintains | Neutral |
| 04/29/2021 | 98.71% | Pivotal Research | → $340 | Upgrades | Hold → Buy |
| 04/23/2021 | 110.4% | Jefferies | → $360 | Initiates Coverage On | → Buy |
| 04/06/2021 | 110.4% | Evercore ISI Group | → $360 | Assumes | → Outperform |
| 04/05/2021 | — | Citigroup | Upgrades | Sell → Neutral | |
| 04/01/2021 | 51.96% | Wolfe Research | → $260 | Initiates Coverage On | → Peer Perform |
| 02/23/2021 | 133.78% | Canaccord Genuity | $375 → $400 | Maintains | Buy |
| 02/23/2021 | 125.01% | JP Morgan | $350 → $385 | Maintains | Overweight |
| 02/23/2021 | 148.39% | Rosenblatt | $390 → $425 | Maintains | Buy |
| 02/10/2021 | 98.71% | Pivotal Research | $260 → $340 | Maintains | Hold |
| 01/27/2021 | — | Nordea Equity | Downgrades | Buy → Hold | |
| 01/21/2021 | 127.94% | Rosenblatt | $325 → $390 | Maintains | Buy |
| 01/15/2021 | 81.18% | Citigroup | $270 → $310 | Downgrades | Neutral → Sell |
| 12/16/2020 | — | Credit Suisse | Downgrades | Outperform → Neutral | |
| 10/27/2020 | 46.11% | Deutsche Bank | $240 → $250 | Maintains | Hold |
| 10/27/2020 | 75.34% | Morgan Stanley | $275 → $300 | Maintains | Overweight |
| 10/14/2020 | 87.03% | Barclays | $310 → $320 | Maintains | Overweight |
| 09/28/2020 | 46.11% | Guggenheim | → $250 | Upgrades | Sell → Neutral |
| 09/15/2020 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
| 09/10/2020 | 84.1% | Credit Suisse | $215 → $315 | Upgrades | Neutral → Outperform |
| 09/09/2020 | — | Raymond James | Reinstates | → Market Perform | |
| 07/30/2020 | 40.27% | Deutsche Bank | $144 → $240 | Maintains | Hold |
| 07/30/2020 | 89.95% | Rosenblatt | $275 → $325 | Maintains | Buy |
| 07/16/2020 | 25.66% | Credit Suisse | $130 → $215 | Maintains | Neutral |
| 07/15/2020 | 69.49% | SunTrust Robinson Humphrey | $167 → $290 | Maintains | Buy |
| 07/14/2020 | 19.23% | UBS | $189 → $204 | Downgrades | Buy → Sell |
| 07/06/2020 | 0.53% | Bernstein | $134 → $172 | Downgrades | Market Perform → Underperform |
| 07/01/2020 | 2.28% | Wells Fargo | $130 → $175 | Maintains | Underweight |
| 06/30/2020 | 57.8% | Citigroup | → $270 | Initiates Coverage On | → Neutral |
| 06/29/2020 | 30.33% | Guggenheim | $170 → $223 | Downgrades | Neutral → Sell |
| 06/29/2020 | 60.72% | Morgan Stanley | $190 → $275 | Maintains | Overweight |
| 06/19/2020 | 60.72% | Rosenblatt | $190 → $275 | Maintains | Buy |
| 05/28/2020 | 5.2% | Redburn Partners | → $180 | Downgrades | Buy → Neutral |
| 04/30/2020 | 8.12% | Canaccord Genuity | $175 → $185 | Maintains | Buy |
| 04/30/2020 | -0.64% | Guggenheim | $135 → $170 | Maintains | Neutral |
| 04/30/2020 | 10.46% | UBS | $172 → $189 | Maintains | Buy |
| 04/30/2020 | -24.02% | Credit Suisse | $125 → $130 | Maintains | Neutral |
| 04/30/2020 | 11.05% | Morgan Stanley | $180 → $190 | Maintains | Overweight |
| 04/30/2020 | 11.05% | Rosenblatt | $184 → $190 | Maintains | Buy |
| 04/24/2020 | -2.4% | SunTrust Robinson Humphrey | $172 → $167 | Maintains | Buy |
| 04/06/2020 | — | Raymond James | Downgrades | Strong Buy → Market Perform | |
| 03/18/2020 | -9.41% | JP Morgan | $170 → $155 | Maintains | Overweight |
| 02/06/2020 | 5.2% | Barclays | $190 → $180 | Maintains | Overweight |
| 02/06/2020 | -0.64% | JP Morgan | $185 → $170 | Maintains | Overweight |
| 02/06/2020 | -26.36% | Wells Fargo | $122 → $126 | Maintains | Underweight |
| 02/05/2020 | -35.71% | Evercore ISI Group | $115 → $110 | Maintains | Underperform |
| 01/17/2020 | 5.2% | UBS | $185 → $180 | Maintains | Buy |
| 01/13/2020 | -32.79% | Evercore ISI Group | → $115 | Downgrades | In-Line → Underperform |
| 01/09/2020 | -25.77% | Bernstein | → $127 | Initiates Coverage On | → Underperform |
| 10/29/2019 | 8.12% | UBS | $182 → $185 | Maintains | Buy |
| 10/29/2019 | 2.28% | Canaccord Genuity | $170 → $175 | Maintains | Buy |
| 10/29/2019 | -15.84% | Deutsche Bank | $130 → $144 | Maintains | Hold |
| 10/29/2019 | -28.7% | Wells Fargo | $115 → $122 | Maintains | Underperform |
| 10/29/2019 | -26.94% | Credit Suisse | $120 → $125 | Maintains | Neutral |
| 10/02/2019 | — | Credit Suisse | Upgrades | Underperform → Neutral | |
| 10/01/2019 | — | Evercore ISI Group | Upgrades | Underperform → In-Line | |
| 09/24/2019 | -32.79% | Wells Fargo | → $115 | Initiates Coverage On | → Underperform |
| 08/20/2019 | — | Consumer Edge Research | Initiates Coverage On | → Equal-Weight | |
| 08/01/2019 | 5.2% | Morgan Stanley | $170 → $180 | Reiterates | → Overweight |
| 08/01/2019 | 2.28% | Stifel | $170 → $175 | Maintains | Buy |
| 08/01/2019 | — | Loop Capital | Upgrades | Sell → Hold | |
| 07/31/2019 | — | Pivotal Research | Downgrades | Buy → Hold | |
| 07/25/2019 | 5.2% | Raymond James | $172 → $180 | Maintains | Strong Buy |
| 06/24/2019 | — | Evercore ISI Group | Downgrades | In-Line → Underperform | |
| 04/30/2019 | 11.05% | Nomura | $188 → $190 | Maintains | Buy |
| 04/30/2019 | 6.37% | UBS | $180 → $182 | Maintains | Buy |
| 04/26/2019 | 0.53% | Raymond James | $182 → $172 | Maintains | Strong Buy |
| 04/22/2019 | -3.57% | Buckingham Research | $174 → $165 | Maintains | Buy |
| 04/16/2019 | 5.2% | UBS | $182 → $180 | Maintains | Buy |
| 03/29/2019 | -29.87% | Credit Suisse | → $120 | Initiates Coverage On | → Underperform |
| 01/11/2019 | -0.64% | Morgan Stanley | $200 → $170 | Maintains | Overweight |
| 01/07/2019 | -21.1% | Deutsche Bank | $152 → $135 | Maintains | Hold |
| 01/07/2019 | -29.87% | Guggenheim | $190 → $120 | Downgrades | Buy → Neutral |
| 11/05/2018 | -12.33% | Wells Fargo | $180 → $150 | Maintains | Market Perform |
| 11/02/2018 | 16.89% | JP Morgan | $225 → $200 | Maintains | Overweight |
| 11/02/2018 | 16.89% | Barclays | $210 → $200 | Maintains | Overweight |
| 11/02/2018 | 11.05% | Nomura | $210 → $190 | Maintains | Buy |
| 10/15/2018 | — | Redburn Partners | Upgrades | → Buy | |
| 10/11/2018 | 11.05% | Buckingham Research | $230 → $190 | Maintains | Buy |
| 07/30/2018 | 16.89% | B. Riley Securities | $156 → $200 | Maintains | Neutral |
| 07/27/2018 | 31.5% | Morgan Stanley | $190 → $225 | Maintains | Overweight |
| 07/27/2018 | 31.5% | Stifel | $200 → $225 | Maintains | Buy |
| 07/27/2018 | 31.5% | JP Morgan | $190 → $225 | Maintains | Overweight |
| 07/25/2018 | — | Pivotal Research | Downgrades | Buy → Hold | |
| 07/23/2018 | 34.42% | BTIG | → $230 | Initiates Coverage On | → Buy |
| 07/20/2018 | 17.48% | Buckingham Research | $195 → $201 | Maintains | Buy |
What is the target price for Spotify Technology (SPOT)?
The latest price target for Spotify Technology (NYSE: SPOT) was reported by Keybanc on July 14, 2023. The analyst firm set a price target for $205.00 expecting SPOT to rise to within 12 months (a possible 19.81% upside). 67 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Spotify Technology (SPOT)?
The latest analyst rating for Spotify Technology (NYSE: SPOT) was provided by Keybanc, and Spotify Technology maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Spotify Technology (SPOT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Spotify Technology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Spotify Technology was filed on July 14, 2023 so you should expect the next rating to be made available sometime around July 14, 2024.
Is the Analyst Rating Spotify Technology (SPOT) correct?
While ratings are subjective and will change, the latest Spotify Technology (SPOT) rating was a maintained with a price target of $180.00 to $205.00. The current price Spotify Technology (SPOT) is trading at is $171.10, which is out of the analyst's predicted range.